期刊
CURRENT OPINION IN HIV AND AIDS
卷 6, 期 1, 页码 4-11出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/COH.0b013e328340ffbb
关键词
HIV chromatin; HIV elongation; HIV initiation; HIV Tat; P-TEFb
资金
- National Institutes of Health [R01-AI067093, DP1-DA028869]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067093] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028869] Funding Source: NIH RePORTER
Purpose of review Despite the remarkable success of intensive antiretroviral drug therapy in blocking the HIV replication, the virus persists in a small number of cells in which HIV has been transcriptionally silenced. This review will focus on recent insights into the HIV transcriptional control mechanisms that provide the biochemical basis for understanding latency. Recent findings Latency arises when the regulatory feedback mechanism driven by HIV Tat expression is disrupted. Small changes in transcriptional initiation, induced by epigenetic silencing, can lead to restrictions in Tat levels and entry of proviruses into latency. In resting memory T-cells, which carry the bulk of the latent viral pool, additional restrictions limiting cellular levels of the essential Tat cofactor P-TEFb and the transcription initiation factors nuclear factor kappa B and nuclear factor of activated T cells ensure that the provirus remains silenced unless the host cell is activated. Summary Strategies to purge the latent proviral pool require nontoxic activator molecules. The multiple restrictions imposed on latent proviruses that need to be overcome suggest that proviral reactivation will not be achieved when only a single reactivation step is targeted but will require both removal of epigenetic blocks and the activation of P-TEFb. Alternatively, new inhibitors that block proviral reactivation could be developed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据